Hot Topics in Tech | June 2018 Newsletter | Maxval

In this issue, we have covered a couple of hot topics that are currently trending in the biotech and cloud-tech industries. We have talked about the FDA’s approval of tisagenlecleucel (KYMRIAH, Novartis Pharmaceuticals Corp.), a CD19-directed genetically modified autologous T-cell immunotherapy, to include treatment of patients with relapsed or refractory large B-cell lymphoma. Tisagenlecleucel is the only CAR T-cell therapy to receive FDA approval for two distinct indications. The report includes a chart of major commercial players in the CAR T-cell space and a Year-on-Year trend on the number of patents and patent applications from 2012 to 2018. We have

Continue reading »

Technology Landscape Study on CRISPR-Cas9

Although CRISPR was known to have an important role in bacterial immunity for over a decade, it is only in the last 5 years that it has garnered interest as a gene editing tool. Increasing investment in this field is indicative of global market opportunities for CRISPR-Cas9 over existing alternatives. The objective of this study is to explore the market and patenting activity in CRISPR-Cas9 gene editing technology. This study considers issued patents and pending published applications related to CRISPR-Cas9 published since January 1, 2007. Search strategies using various combinations of keywords, classification codes, and prominent assignees resulted in more

Continue reading »

MaxVal to Sponsor and Exhibit at IPBC Global, San Francisco (June 10-12, 2018)

MaxVal is sponsoring the 11th annual event of IP Business Congress Global (IPBC), to be held from June 10-12, 2018 at Palace Hotel, San Francisco. IPBC is an established gathering for the World’s IP Business leaders ensuring extensive formal and informal networking opportunities. Its unrivaled coverage and in-depth analysis of key sectors provide executives critical business intelligence to maximize the IP value. As an exhibiting sponsor, MaxVal will demonstrate its end-to-end IP Management platform, Symphony, known for its robustness, reliability, and automation in handling the complete IP lifecycle. “I’m proud to be a part of the company that has created Symphony

Continue reading »

Recent advances in Diabetes Management | April 2018 Newsletter | MaxVal

The article addresses Medtronic’s recent FDA approval of the Guardian™ Connect Continuous Glucose Monitoring (CGM) system. A brief overview of all the clinical studies related to CGM has been presented. It also analyzes the recent findings on a microneedle system for non-invasive insulin delivery. A birds-eye view of patent filings related to microneedles for insulin delivery, with a focus on global players is presented.

Continue reading »

MaxVal Exhibits at INTA 140th Annual Meeting, Seattle, WA (May 19-23, 2018)

MaxVal is exhibiting at INTA 140th Annual meeting at Booth #418, to be held from May 19-23 at Washington State Convention Center, Seattle, WA. INTA’s (International Trademark Association) Annual Meeting is recognized as one of the premier events for the trademark industry which is expected to attract more than 10,000 attendees from around the world. Brand owners, in-house counsel, law firms, government officials, and other IP experts will gather in this 140th annual meeting to discuss and examine the key industry issues, challenges, and opportunities in the ever-growing IP landscape. MaxVal, a preferred IP management partner for law firms and

Continue reading »

MaxVal is Exhibiting at the AIPLA Spring Meeting, Seattle, WA (May 15-17, 2018)

MaxVal will be exhibiting at the AIPLA 2018 Spring Meeting at Booth #1 , on May 15-17, 2018 (The Westin Seattle in Seattle, WA). The AIPLA (American Intellectual Property Law Association) meeting usually draws a varied group of over 600 IP professionals for its Spring meeting,  to discuss and exchange views on best practices and issues in IP management, as well as to keep up with latest developments and trends in the IP domain. The Association also hosts different networking events for the attendees to build professional and business connections. In this event, MaxVal will be exhibiting its latest applications and

Continue reading »

MaxVal celebrated World IP Day on April 26, 2018

MaxVal celebrated the World IP Day at its India locations at Coimbatore and Chennai on April 26, 2018. WIPO has designated April 26 every year as World Intellectual Property Day to promote discussion on the role of IP in encouraging innovation and creativity. It is observed worldwide in over 180 member countries of WIPO through different outreach programs. To mark this event, MaxVal hosted a range of activities and events in line with the theme for 2018, “Powering change: Women in innovation and creativity”. The main objective of the program was to raise public awareness amongst employees about the basic

Continue reading »

MaxVal to Sponsor and Exhibit at IP Counsel Cafe – April 25-27, 2018

MaxVal, an IP lifecycle management company, announced that it will be sponsoring IP Counsel Cafe (Annual Silicon Valley Conference) for the second year in a row, to be held from April 25-27, 2018 in Palo Alto, CA. IP Counsel Café 2018 is one of the largest gatherings of IP leaders where IP professionals can learn more about protecting their IP assets globally. In order to create and protect IP on a global scale without penalty, at home as well as abroad. “Last year, we demonstrated our flagship product Symphony® (end-to-end Intellectual Property Management platform), and we are excited to be

Continue reading »

Want your patent renewals to be cost-effective? Consider these tips

IP strategists suggest that having a right strategy in place right from the outset of invention disclosure will help companies cut down their overall patent maintenance costs. With a little planning and preparation, you can learn how to manage your costs and achieve significant savings. Established companies, regardless of their assets or market values, look for every possible way to reduce direct and indirect costs. Patent renewal is one area where innovative companies hunt for opportunities to reduce the maintenance costs as much as possible. Anyone familiar with patent renewals would know how painful a process it can be and

Continue reading »